DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps

Abstract

We call for the AD field to move beyond discrete biomarkers and utilize the full power of informatics and big data approaches to build and test personalized markers at a pathway and network level. While we have chosen AD as an example, the issues we propose are also highly relevant to other neurodegenerative disorders, such as vascular dementia or dementia with Lewy bodies, where even less is known about how various biomarkers interact. Indeed, the availability of rich biomarker data across a range of neurodegenerative disorders would enable more accurate pathology-based classification of such conditions (as opposed to the current predominantly clinical classifications). We further hypothesize that building dynamic network biomarkers and pathway crosstalk reference maps using the combined power of several protein/gene-level knowledge priors could accelerate discovery of disease-specific mechanisms and novel drug targets by enrichment with patient specific genetic information. Application of this methodology to large public AD datasets is needed to test our hypotheses and refine the methods. Subsequent replication in independent datasets and population studies as well as functional validation of mechanisms in laboratory models will be the next steps. Ultimately, it is our hope that such novel methods may yield further insights into both diseasemore » mechanisms as well as novel targets for biomarker development and drug discovery.« less

Authors:
 [1];  [2];  [3];  [4];  [5]
  1. North Carolina State Univ., Raleigh, NC (United States). Dept. of Computer Science; Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Computer Science and Mathematics Division
  2. Stanford Univ., CA (United States). School of Medicine
  3. North Carolina State Univ., Raleigh, NC (United States). Dept. of Computer Science
  4. Duke Univ., Durham, NC (United States). Dept. of Psychiatry; Duke Univ., Durham, NC (United States). Duke Inst. for Brain Sciences
  5. North Carolina State Univ., Raleigh, NC (United States). Dept. of Computer Science; Oak Ridge National Lab. (ORNL), Oak Ridge, TN (United States). Computer Science and Mathematics Division
Publication Date:
Research Org.:
Oak Ridge National Laboratory (ORNL), Oak Ridge, TN (United States)
Sponsoring Org.:
USDOE Office of Science (SC), Biological and Environmental Research (BER). Biological Systems Science Division
OSTI Identifier:
1629468
Grant/Contract Number:  
AC05-00OR22725
Resource Type:
Accepted Manuscript
Journal Name:
Frontiers in aging neuroscience
Additional Journal Information:
Journal Volume: 9; Journal ID: ISSN 1663-4365
Publisher:
Frontiers
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES; Alzheimer’s disease; pathways; crosstalk; SNP data; bioinformatics; biomarker

Citation Formats

Padmanabhan, Kanchana, Shpanskaya, Katie, Bello, Gonzalo, Doraiswamy, P. Murali, and Samatova, Nagiza F. Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps. United States: N. p., 2017. Web. doi:10.3389/fnagi.2017.00315.
Padmanabhan, Kanchana, Shpanskaya, Katie, Bello, Gonzalo, Doraiswamy, P. Murali, & Samatova, Nagiza F. Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps. United States. https://doi.org/10.3389/fnagi.2017.00315
Padmanabhan, Kanchana, Shpanskaya, Katie, Bello, Gonzalo, Doraiswamy, P. Murali, and Samatova, Nagiza F. Tue . "Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps". United States. https://doi.org/10.3389/fnagi.2017.00315. https://www.osti.gov/servlets/purl/1629468.
@article{osti_1629468,
title = {Toward Personalized Network Biomarkers in Alzheimer's Disease: Computing Individualized Genomic and Protein Crosstalk Maps},
author = {Padmanabhan, Kanchana and Shpanskaya, Katie and Bello, Gonzalo and Doraiswamy, P. Murali and Samatova, Nagiza F.},
abstractNote = {We call for the AD field to move beyond discrete biomarkers and utilize the full power of informatics and big data approaches to build and test personalized markers at a pathway and network level. While we have chosen AD as an example, the issues we propose are also highly relevant to other neurodegenerative disorders, such as vascular dementia or dementia with Lewy bodies, where even less is known about how various biomarkers interact. Indeed, the availability of rich biomarker data across a range of neurodegenerative disorders would enable more accurate pathology-based classification of such conditions (as opposed to the current predominantly clinical classifications). We further hypothesize that building dynamic network biomarkers and pathway crosstalk reference maps using the combined power of several protein/gene-level knowledge priors could accelerate discovery of disease-specific mechanisms and novel drug targets by enrichment with patient specific genetic information. Application of this methodology to large public AD datasets is needed to test our hypotheses and refine the methods. Subsequent replication in independent datasets and population studies as well as functional validation of mechanisms in laboratory models will be the next steps. Ultimately, it is our hope that such novel methods may yield further insights into both disease mechanisms as well as novel targets for biomarker development and drug discovery.},
doi = {10.3389/fnagi.2017.00315},
journal = {Frontiers in aging neuroscience},
number = ,
volume = 9,
place = {United States},
year = {Tue Sep 26 00:00:00 EDT 2017},
month = {Tue Sep 26 00:00:00 EDT 2017}
}

Works referenced in this record:

Crosstalk in NF-κB signaling pathways
journal, July 2011

  • Oeckinghaus, Andrea; Hayden, Matthew S.; Ghosh, Sankar
  • Nature Immunology, Vol. 12, Issue 8
  • DOI: 10.1038/ni.2065

Xtalk: a path-based approach for identifying crosstalk between signaling pathways
journal, September 2015


A global pathway crosstalk network
journal, April 2008


A Human Protein-Protein Interaction Network: A Resource for Annotating the Proteome
journal, September 2005


Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
journal, September 2007

  • Ballatore, Carlo; Lee, Virginia M. -Y.; Trojanowski, John Q.
  • Nature Reviews Neuroscience, Vol. 8, Issue 9
  • DOI: 10.1038/nrn2194

Biological Process Linkage Networks
journal, April 2009


Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach
journal, April 2017


National estimates of the prevalence of Alzheimer's disease in the United States
journal, January 2011


The identification of dysfunctional crosstalk of pathways in Parkinson disease
journal, February 2013


Alzheimer's Disease: Genes, Proteins, and Therapy
journal, April 2001


A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer’s disease
journal, June 2016

  • Liu, Haochen; Zhou, Xiaoting; Jiang, Hao
  • Scientific Reports, Vol. 6, Issue 1
  • DOI: 10.1038/srep26712

Prediction of human protein–protein interaction by a mixed Bayesian model and its application to exploring underlying cancer-related pathway crosstalk
journal, October 2010

  • Xu, Yan; Hu, Wen; Chang, Zhiqiang
  • Journal of The Royal Society Interface, Vol. 8, Issue 57
  • DOI: 10.1098/rsif.2010.0384

Inferring pathway crosstalk networks using gene set co-expression signatures
journal, January 2013

  • Wang, Ting; Gu, Jin; Yuan, Jun
  • Molecular BioSystems, Vol. 9, Issue 7
  • DOI: 10.1039/c3mb25506a

Complex biomarker discovery in neuroimaging data: Finding a needle in a haystack
journal, January 2013


Crosstalk pathways between Toll-like receptors and the complement system
journal, April 2010


Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD
journal, June 2011


Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
journal, February 2017


Pathway mapping and development of disease‐specific biomarkers: protein‐based network biomarkers
journal, January 2015

  • Chen, Hao; Zhu, Zhitu; Zhu, Yichun
  • Journal of Cellular and Molecular Medicine, Vol. 19, Issue 2
  • DOI: 10.1111/jcmm.12447

The identification of dysfunctional crosstalk of pathways in Parkinson disease
journal, February 2013


Crosstalk pathways between Toll-like receptors and the complement system
journal, April 2010


Potential of GPCRs to modulate MAPK and mTOR pathways in Alzheimer’s disease
journal, February 2017


Alzheimer's disease
journal, March 2011


Crosstalk in NF-κB signaling pathways
journal, July 2011

  • Oeckinghaus, Andrea; Hayden, Matthew S.; Ghosh, Sankar
  • Nature Immunology, Vol. 12, Issue 8
  • DOI: 10.1038/ni.2065

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
journal, September 2007

  • Ballatore, Carlo; Lee, Virginia M. -Y.; Trojanowski, John Q.
  • Nature Reviews Neuroscience, Vol. 8, Issue 9
  • DOI: 10.1038/nrn2194

Inferring pathway crosstalk networks using gene set co-expression signatures
journal, January 2013

  • Wang, Ting; Gu, Jin; Yuan, Jun
  • Molecular BioSystems, Vol. 9, Issue 7
  • DOI: 10.1039/c3mb25506a

A global pathway crosstalk network
journal, April 2008


Alzheimer's Disease: Genes, Proteins, and Therapy
journal, April 2001


Discovering pathway cross-talks based on functional relations between pathways
journal, December 2012


Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains
journal, September 2010


Analyzing the genes related to Alzheimer’s disease via a network and pathway-based approach
journal, April 2017


Biological Process Linkage Networks
journal, April 2009


Unfolded p53: A Potential Biomarker for Alzheimer's Disease
journal, August 2007

  • Lanni, Cristina; Uberti, Daniela; Racchi, Marco
  • Journal of Alzheimer's Disease, Vol. 12, Issue 1
  • DOI: 10.3233/jad-2007-12109

Works referencing / citing this record:

Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain
journal, November 2018

  • Riedel, Brandalyn C.; Daianu, Madelaine; Ver Steeg, Greg
  • Frontiers in Aging Neuroscience, Vol. 10
  • DOI: 10.3389/fnagi.2018.00390

Neurodegeneration research: Advances in clinical translational neuroscience infrastructure and methods
journal, January 2018

  • Cummings, Jeffrey L.; Fulkerson, Nadia
  • Alzheimer's & Dementia: Translational Research & Clinical Interventions, Vol. 4, Issue 1
  • DOI: 10.1016/j.trci.2018.03.008

Uncovering Biologically Coherent Peripheral Signatures of Health and Risk for Alzheimer’s Disease in the Aging Brain
journal, November 2018

  • Riedel, Brandalyn C.; Daianu, Madelaine; Ver Steeg, Greg
  • Frontiers in Aging Neuroscience, Vol. 10
  • DOI: 10.3389/fnagi.2018.00390